Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients
- PMID: 8556965
- DOI: 10.1016/0376-8716(95)01154-9
Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients
Abstract
We tested the efficacy of amantadine to reduce cocaine use or craving in cocaine-dependent methadone maintained patients. Two doses of amantadine (200 mg p.o. daily, n = 16, and 200 mg p.o. bid, n = 21) were tested against placebo, n = 22, in a random assignment, double-blind clinical trial lasting nine weeks. Amantadine was well tolerated. However, neither dose of amantadine was more effective than placebo in reducing cocaine use and craving.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
